1 year return (CAGR)
-36.93%
Novo Nordisk A/S Exchange (NYSE, USD)
NVO
37.54
-0.08 (-0.21%)
HealthcareDrug Manufacturers - General
Loading...
3 year return (CAGR)
-25.89%
5 year return (CAGR)
-6.07%
10 year return (CAGR)
4.91%
Novo Nordisk (NVO) Stock Analysis and Outlook
Read MoreMarketcap
124.68B
Price/Sales
0.38
Ent value
453.86B
Price/Book
-
Div yield
3.10%
Growth years
3
Div growth
20.29%
FCF payout
68.62%
Trailing P/E
1.07
PEG
0.78
Forward P/E
1.69
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 37.63 |
| Daily high | 37.65 |
| Daily low | 37.17 |
| Daily Volume | 10.1M |
| All-time high | 146.91 |
| 1y analyst estimate | 46.14 |
| Beta | 0.34 |
| EPS (TTM) | 26.25 |
| Dividend per share | 1.16 |
| Ex-div date | 17 Aug 2026 |
| Next earnings date | 6 May 2026 |
Downside potential
Loading...
Downside potential data
| NVO | S&P500 | |
| Current price drop from All-time high | -74.45% | -0.39% |
| Highest price drop | -75.98% | -56.47% |
| Date of highest drop | 30 Mar 2026 | 9 Mar 2009 |
| Avg drop from high | -13.47% | -10.67% |
| Avg time to new high | 16 days | 12 days |
| Max time to new high | 1120 days | 1805 days |
News
